Regulation of inhibin β chains and follistatin mRNA levels during rat hepatocyte growth induced by the peroxisome proliferator di-n-butyl phthalate

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 9, 2002, Pages 1214-1216

  Kobayashi, Tetsu ^a   Niimi, Shingo ^a   Fukuoka, Masamichi ^b   Hayakawa, Takao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Follistatin; Hepatocyte growth; Inhibin chain; Peroxisome proliferator

Indexed keywords

FOLLISTATIN; INHIBIN B; MESSENGER RNA; PEROXISOME PROLIFERATOR; INHIBIN; PHTHALIC ACID DIBUTYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; LIVER CELL; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; METABOLISM; WISTAR RAT;

ANIMALS; DIBUTYL PHTHALATE; FOLLISTATIN; HEPATOCYTES; INHIBIN-BETA SUBUNITS; MALE; PEROXISOME PROLIFERATORS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0036726659     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1214     Document Type: Article

References (23)

1. Ohmura T., Ledda-Columbano G. M., Piga R., Columbano A., Glemba J., Katyal S. L., Locker J., Shinozuka H., Am. J. Pathol., 148, 815-824 (1996).
2. Columbano A., Shinozuka H., FASEB J., 10, 1118-1128 (1996).
3. Roberts R. A., James N. H., Woodyatt N. J., Macdonald N., Tugwood J. D., Carcinogenesis, 19, 43-48 (1998).
4. Kren B. T., Trembley J. H., Fan G., Steer C. J., Ann. N.Y. Acad. Sci., 831, 361-381 (1997).
5. Michalopoulos G. K., FASEB J., 4, 176-187 (1990).
6. Shinozuka H., Kubo Y., Katyal S. L., Conti P., Ledda-Columbano G. M., Columbano A., Nakamura T., Lab. Invest., 71, 35-44 (1994).
7. Masuhara M., Katyal S. L., Nakamura T., Shinozuka H., Hepatology, 16, 1241-1249 (1992).
8. Grasl-Kraupp B., Rossmanith W., Ruttkay-Nedecky B., Mullauer L., Kammerer B., Bursch W., Schulte-Hermann R., Hepatology, 28, 717-726 (1998).
9. Yasuda H., Mine T., Shibata H., Eto Y., Hasegawa Y., Takeuchi T., Asano S., Kojima I., J. Clin. Invest., 92, 1491-1496 (1993)
10. Kawashima Y., Hanioka N., Matsumura M., Kozuka H., Biochim. Biophys. Acta, 752, 259-264 (1983).
11. Okita R. T., Okita J. R., Pharmaceut. Res., 9, 1648-1652 (1992).
12. Tharappel J. C., Cunningham M. L., Spear B. T., Glauert H. P., Toxicol. Sci., 62, 20-27 (2001).
13. Ogawa K., Abe K., Kurosawa N., Kurohmaru M., Sugino H., Takahashi M., Hayashi Y., FEBS Lett., 319, 217-220 (1993).
14. Uno S., Nakamura M., Seki T., Ariga T., Biochem. Biophys. Res. Commun., 239, 123-128 (1997).
15. Gill J. H., Brickell P., Dive C., Roberts R. A., Carcinogenesis, 19, 1743-1747 (1998).
16. Zauberman A., Oren M., Zipori D., Oncogene, 15, 1705-1711 (1997).
17. Nakamura T., Takio K., Eto Y., Shibai H., Titani K., Sugino H., Science, 247, 836-838 (1990).
18. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., Woo W., Karr D., Spiess J., Nature (London), 321, 776-779 (1986).
19. Ling N., Ying S.-Y., Ueno N., Shimasaki S., Esch F., Hotta M., Guillemin R., Nature (London), 321, 779-782 (1986).
20. Nakamura T., Asashima M., Eto Y., Takio K., Uchiyama H., Moriya N., Ariizumi T., Yashiro T., Sugino K., Titani K., Sugino H., J. Biol. Chem., 267, 16385-16389 (1992).
21. Niimi S., Horikawa M., Seki T., Ariga T., Kobayashi T., Hayakawa T., Biol. Pharm. Bull., 25, 437-440 (2002).
22. Mellor S. L., Cranfield M., Ries R., Pedersen J., Cancilla B., de Kretser D., Groome N. P., Mason A. J., Risbridger G. P., J. Clin. Endocrinol. Metab., 65, 4851-4858 (2000).
23. Kobayashi T., Niimi S., Hashimoto O., Hayakawa T., Biol. Pharm. Bull., 23, 755-757 (2000).